Aeromedical Consult Service, United States Air Force School of Aerospace Medicine, Wright-PAtterson AFB, Ohio, USA.
Canadian Forces Environmental Medical Establishment, Toronto, Ontario, Canada.
Heart. 2019 Jan;105(Suppl 1):s25-s30. doi: 10.1136/heartjnl-2018-313054.
This paper is part of a series of expert consensus documents covering all aspects of aviation cardiology. In this manuscript, we focus on the broad aviation medicine considerations that are required to optimally manage aircrew with established coronary artery disease in those without myocardial infarction or revascularisation (both pilots and non-pilot aviation professionals). We present expert consensus opinion and associated recommendations. It is recommended that in aircrew with non-obstructive coronary artery disease or obstructive coronary artery disease not deemed haemodynamically significant, nor meeting the criteria for excessive burden (based on plaque morphology and aggregate stenosis), a return to flying duties may be possible, although with restrictions. It is recommended that aircrew with haemodynamically significant coronary artery disease (defined by a decrease in fractional flow reserve) or a total burden of disease that exceeds an aggregated stenosis of 120% are grounded. With aggressive cardiac risk factor modification and, at a minimum, annual follow-up with routine non-invasive cardiac evaluation, the majority of aircrew with coronary artery disease can safely return to flight duties.
本文是一系列涵盖航空心脏病学各个方面的专家共识文件的一部分。在本手稿中,我们重点关注那些已经患有冠状动脉疾病但没有心肌梗死或血运重建(飞行员和非飞行员航空专业人员)的机组人员的广泛航空医学考虑因素。我们提出了专家共识意见和相关建议。建议在非阻塞性冠状动脉疾病或阻塞性冠状动脉疾病但不认为血流动力学显著,也不符合过度负担标准(基于斑块形态和总狭窄)的机组人员中,可能可以恢复飞行任务,但需要限制。建议血流动力学显著的冠状动脉疾病(定义为血流储备分数降低)或总疾病负担超过 120%的总狭窄的机组人员停飞。通过积极的心脏危险因素修正,至少每年进行一次常规非侵入性心脏评估,大多数患有冠状动脉疾病的机组人员可以安全地恢复飞行任务。